Deprecated!
This application is deprecated. Please use the latest version of the tool here.
Please cite:
I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni, G. Georgakilas, T. Vergoulis, I. Kanellos, I-L. Anastasopoulos, S. Maniou, K. Karathanou, D. Kalfakakou, A. Fevgas, T. Dalamagas and A. G. Hatzigeorgiou. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucl. Acids Res. (2014)
Data Download:
DIANA-TarBase v7 is available for scientific non-profit and non-commercial use! Download TarBase v7 by following this link
|
||||||||
Related Pathways
Publication year
Prediction score
Filters
Selected:
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Remove all 

Species

Method Type

Method

Regulation type

Validation type

Validated as

Source

Publication year
Prediction score
Loading...![]() |
Wait until the result set is completed... |
Gene name
miRNA name
Methods
Pred.Score
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:149964925-149964947 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:35920628-35920644 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:109311796-109311816 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:109311300-109311327 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:109311300-109311327 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:109311300-109311327 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:66723213-66723222 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:100550848-100550876 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:100549337-100549358 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:207049159-207049180 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:207049159-207049180 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:58448133-58448148 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:10444153-10444179 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:10444153-10444179 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr2:10444153-10444179 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr2:10444153-10444179 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:160104831-160104844 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:36883934-36883957 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:49020022-49020031 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr12:49020022-49020031 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:49020022-49020031 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:112459514-112459542 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:49611371-49611392 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:49611371-49611392 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:10770551-10770575 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:132010847-132010869 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:9935607-9935627 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:85247113-85247138 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chrX:85247113-85247138 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chrX:85264394-85264419 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:23574247-23574272 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:1257719-1257742 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:1257719-1257742 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:1257719-1257742 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:46608907-46608920 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:49874170-49874191 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:10805976-10805998 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:10802392-10802415 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ADORA1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:203166225-203166243 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF772 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:57475721-57475739 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CPEB2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:15003188-15003197 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BSG (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:582288-582309 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EEF1D (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:143596694-143596720 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
OAZ1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:2273409-2273436 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CTB-50L17.10 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:4494360-4494388 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TESK1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:35606004-35606026 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ISYNA1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:18436099-18436125 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:18436099-18436125 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PRRC2B (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:131495798-131495818 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TANK (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:161231025-161231052 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CHORDC1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:90201956-90201983 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DDX42 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:63799600-63799621 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
USP32 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:60391946-60391955 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
LYRM4 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:5104837-5104860 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HSP90AB1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:44250312-44250329 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PLS3 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:115610265-115610289 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SYNCRIP (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:85640537-85640558 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MGAT4C (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:85966349-85966368 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GPAT2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:96024816-96024831 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FAM180B (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:47586701-47586719 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HIGD1C (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:50954022-50954031 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DGKD (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:233471404-233471424 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr2:233459778-233459792 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PPP1R9B (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:50139552-50139574 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NDUFAF5 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:13817547-13817574 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
LENG8 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:54459778-54459787 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GNLY (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:85695373-85695384 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ATP2B1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr12:89588343-89588367 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NDUFAB1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:23581140-23581164 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:23581140-23581164 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FNIP1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:131719375-131719393 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SRRT (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:100881643-100881665 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DHX30 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:47846280-47846302 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TMEM107 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:8173541-8173565 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr17:8173541-8173565 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:8173541-8173565 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:8173541-8173565 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr17:8173541-8173565 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr17:8173541-8173565 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
UBR4 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:19105147-19105168 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:19110804-19110811 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
AJUBA (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:22982090-22982112 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PRRC2A (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:31637516-31637538 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:31626823-31626845 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SAMD15 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:77378713-77378732 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RBM14 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:66627017-66627027 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NCKAP1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:183001979-183001999 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:182967298-182967320 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BCOR (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:40071126-40071149 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HEXIM1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:45148624-45148633 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TNC (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:115086822-115086840 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MZT1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr13:72710299-72710327 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
STK25 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:241501562-241501590 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ADNP (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:50891549-50891568 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DDX5 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:64502465-64502475 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TMCC1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:129648953-129648981 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:129648243-129648269 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EIF4G1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:184321262-184321285 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:184322628-184322651 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ARID1A (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:26774812-26774819 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
KIDINS220 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:8734693-8734719 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NRD1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:51836163-51836181 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
XPO6 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:28211548-28211575 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
WDR33 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:127713637-127713658 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF395 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:28356748-28356771 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EEF2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:3980931-3980949 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FKBP1C (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:63211746-63211759 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RPL35A (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:197951241-197951260 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HNRNPUL2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:62720055-62720063 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MCM2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:127604646-127604671 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HECTD1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:31122972-31122993 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr14:31122959-31122981 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
C1orf123 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:53214330-53214353 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TRIP12 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:229813925-229813952 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NCL (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:231461592-231461620 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr2:231461592-231461620 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:231461592-231461620 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr2:231460767-231460789 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:231463242-231463252 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
APP (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr21:26021958-26021981 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SRSF2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:76734541-76734569 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:76734541-76734569 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CHST14 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:40471395-40471418 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HMGB2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:173333139-173333160 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:173333139-173333160 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SNX9 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:157921634-157921658 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
URB2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:229659523-229659542 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:229659523-229659542 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RANBP10 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:67723472-67723494 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RPL37 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:40829278-40829300 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FAM127A (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:135032665-135032687 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HSP90AA1 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:102081743-102081761 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr14:102081743-102081761 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GTF3C4 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:132689169-132689182 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
AATK (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:81118238-81118248 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF276 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:89738607-89738614 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EFCAB14 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:46675744-46675765 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:46675744-46675765 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BICD2 (hsa) 

hsa-miR-452-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:92712930-92712954 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0